We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novavax Starts COVID-19 Vaccine Late-Stage Trial in U.S. and Mexico
Novavax Starts COVID-19 Vaccine Late-Stage Trial in U.S. and Mexico
Novavax has launched a phase 3 study in the U.S. and Mexico to evaluate its COVID-19 vaccine candidate, NVX-CoV2373, after deferring the trial for two months because of holdups in securing doses.